Stockreport

Immunomedics' lead ADC shows positive action in subgroup of treatment-resistant breast cancer patients; shares up 8% premarket [Seeking Alpha]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF Immunomedics' lead ADC shows positive action in subgroup of treatment-resistant breast cancer patients; shares up 8% premarketImmunomedics (NASDAQ:IMMU) is up8% premarke [Read more]